---
title: "Abbott wins dismissal of shareholder lawsuit over 2022 infant formula recall"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293792909.md"
datetime: "2026-07-24T20:05:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293792909.md)
  - [en](https://longbridge.com/en/news/293792909.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293792909.md)
---

# Abbott wins dismissal of shareholder lawsuit over 2022 infant formula recall

July 24 (Reuters) - A federal judge on Friday dismissed a lawsuit accusing Abbott Laboratories (ABT.N) of defrauding shareholders in connection with a 2022 recall of powdered infant formula, and lying about its commitment to quality and product safety.

U.S. District Judge Steven Seeger in Chicago said that despite filing a 217-page complaint, shareholders failed to state claims against Abbott or any individual defendants.

### Related Stocks

- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)

## Related News & Research

- [23:20 ETPRIVACY ALERT: Abbott Laboratories and Exact Sciences Corporation Under Investigation for Data Breach of Patient Records](https://longbridge.com/en/news/293695963.md)
- [These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results](https://longbridge.com/en/news/293046426.md)
- [This is when the federal debt actually matters](https://longbridge.com/en/news/293803874.md)
- [Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street](https://longbridge.com/en/news/292936857.md)
- [13:11 ETFEDERAL HOME LOAN BANK OF BOSTON ANNOUNCES 2026 SECOND QUARTER RESULTS, DECLARES DIVIDEND](https://longbridge.com/en/news/293783122.md)